Drug Shortage Report for ONDANSETRON INJECTION, USP
| Report ID | 13535 |
| Drug Identification Number | 02390019 |
| Brand name | ONDANSETRON INJECTION, USP |
| Common or Proper name | ONDANSETRON INJECTION, USP |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ONDANSETRON |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 4ML 5VL, 2ML 5VL |
| ATC code | A04AA |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-09-17 |
| Estimated end date | 2018-10-30 |
| Actual end date | 2018-10-19 |
| Shortage status | Resolved |
| Updated date | 2018-10-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-06-21 | English | Compare |